![Health Justice Initiative - HJI (@healthjusticein) 's Twitter Profile](https://pbs.twimg.com/profile_images/1574772140599132162/ZFdUmp58_200x200.jpg)
Health Justice Initiative - HJI
@healthjusticein
Dedicated law & policy unit focusing on intersection between health rights, inequality & justice.
@[email protected]
[email protected]
ID: 1268825380292571136
https://www.healthjusticeinitiative.org.za 05-06-2020 08:42:39
7,7K Tweet
3,3K Followers
878 Following
![MSF Access Campaign (@msf_access) 's Twitter Profile Photo MSF Access Campaign (@msf_access) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/611076942440214529/q19Lhhlh_200x200.png)
Tomorrow, a US Senate committee meets to ask what we all want to know - "why Novo Nordisk is charging outrageously high prices for diabetes medicines” Our research found, Novo Nordisk & Eli Lilly and Company sell diabetes drugs at up to 40,000% markup! 🤯 🔗msfaccess.org/new-msf-report…
![MSF Access Campaign (@msf_access) on Twitter photo Tomorrow, a US Senate committee meets to ask what we all want to know - "why Novo Nordisk is charging outrageously high prices for diabetes medicines”
Our research found, <a href="/novonordisk/">Novo Nordisk</a> & <a href="/EliLillyandCo/">Eli Lilly and Company</a> sell diabetes drugs at up to 40,000% markup! 🤯
🔗msfaccess.org/new-msf-report… Tomorrow, a US Senate committee meets to ask what we all want to know - "why Novo Nordisk is charging outrageously high prices for diabetes medicines”
Our research found, <a href="/novonordisk/">Novo Nordisk</a> & <a href="/EliLillyandCo/">Eli Lilly and Company</a> sell diabetes drugs at up to 40,000% markup! 🤯
🔗msfaccess.org/new-msf-report…](https://pbs.twimg.com/media/GYLPpYhWIAAecof.jpg)
![Madhu Pai, MD, PhD (@paimadhu) 's Twitter Profile Photo Madhu Pai, MD, PhD (@paimadhu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1817368589403328513/9wYMUyMb_200x200.jpg)
A case study of the WHO’s mRNA technology transfer programme in South Africa an initiative "largely in line with dominant approaches to vaccine production, steeped in the neocolonial dynamics" Matthew Herder & Ximena Benavides via PLOS Global Public Health journals.plos.org/globalpubliche…
![Madhu Pai, MD, PhD (@paimadhu) on Twitter photo A case study of the WHO’s mRNA technology transfer programme in South Africa
an initiative "largely in line with dominant approaches to vaccine production, steeped in the neocolonial dynamics"
<a href="/cmrherder/">Matthew Herder</a> & <a href="/XSBenavides/">Ximena Benavides</a> via <a href="/PLOSGPH/">PLOS Global Public Health</a>
journals.plos.org/globalpubliche… A case study of the WHO’s mRNA technology transfer programme in South Africa
an initiative "largely in line with dominant approaches to vaccine production, steeped in the neocolonial dynamics"
<a href="/cmrherder/">Matthew Herder</a> & <a href="/XSBenavides/">Ximena Benavides</a> via <a href="/PLOSGPH/">PLOS Global Public Health</a>
journals.plos.org/globalpubliche…](https://pbs.twimg.com/media/GYLu685XUAA7MLZ.jpg)
![Amy Maxmen, PhD (@amymaxmen) 's Twitter Profile Photo Amy Maxmen, PhD (@amymaxmen) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1568041269389152257/hwcuAY6q_200x200.jpg)
A new & incredibly detailed review of the WHO mRNA hub by Matthew Herder Ximena Benavides. Beyond the question of whether it can deliver, they find that the architecture of the project makes it unlikely to improve equitable access to mRNA drugs & vaccines. journals.plos.org/globalpubliche…
![Jake Atkinson (@jacoblatkinson) 's Twitter Profile Photo Jake Atkinson (@jacoblatkinson) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1681067606663364608/4Xc2vNVQ_200x200.jpg)
NEW: Activists ACT UP London are demanding Gilead make Lenacapavir, a twice-yearly & highly effective injectable HIV prevention drug, accessible globally with generic production. It could be ~$40 per person per year with profit but Gilead are charging $40,000+! 1/3
![ACT UP London (@actup_ldn) 's Twitter Profile Photo ACT UP London (@actup_ldn) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/828939337433755657/7DbVQw1f_200x200.jpg)
![Roz Scourse (@rozscourse) 's Twitter Profile Photo Roz Scourse (@rozscourse) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1784611179819663360/zWiwt4II_200x200.jpg)
Diabetes meds like #Ozempic are sold at up to 40,000% markup while patients struggle to access them. They can be sold at profit for $0.89/month, but costs $115 in South Africa & $353 in the US. MSF Access Campaign is demanding Eli Lilly and Company Novo Nordisk Sanofi make them affordable
![ACT UP London (@actup_ldn) 's Twitter Profile Photo ACT UP London (@actup_ldn) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/828939337433755657/7DbVQw1f_200x200.jpg)
![Fatima Hassan @FatimaHassan@mastodon.social (@_hassanf) 's Twitter Profile Photo Fatima Hassan @FatimaHassan@mastodon.social (@_hassanf) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1450936975104544770/WGQzd0CS_200x200.jpg)
![Initiative for Medicines, Access & Knowledge (@imakglobal) 's Twitter Profile Photo Initiative for Medicines, Access & Knowledge (@imakglobal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/922973654849343489/RxOp0eNq_200x200.jpg)
Today is the 40th anniversary of the Hatch-Waxman Act. In our new video, Tahir Amin explains how the Act came to be and how Pharma turned it into a tool to extend drug patent monopolies and keep drug prices sky-high.
![Tahir Amin (@realtahiramin) 's Twitter Profile Photo Tahir Amin (@realtahiramin) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1718114737362190336/qY5LEYQV_200x200.jpg)
![Fatima Hassan @FatimaHassan@mastodon.social (@_hassanf) 's Twitter Profile Photo Fatima Hassan @FatimaHassan@mastodon.social (@_hassanf) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1450936975104544770/WGQzd0CS_200x200.jpg)
You can read the article Brook & I wrote in 2023 about the mRNA WHO MPP Program here: healthjusticeinitiative.org.za/2023/09/18/pan… You can read the outcome of Matthew Herder + Ximena Benavides excellent case study (based also on several hard hitting interviews) on the Program here: journals.plos.org/globalpubliche…
![Health Justice Initiative - HJI (@healthjusticein) 's Twitter Profile Photo Health Justice Initiative - HJI (@healthjusticein) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1574772140599132162/ZFdUmp58_200x200.jpg)
![Fatima Hassan @FatimaHassan@mastodon.social (@_hassanf) 's Twitter Profile Photo Fatima Hassan @FatimaHassan@mastodon.social (@_hassanf) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1450936975104544770/WGQzd0CS_200x200.jpg)
![Initiative for Medicines, Access & Knowledge (@imakglobal) 's Twitter Profile Photo Initiative for Medicines, Access & Knowledge (@imakglobal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/922973654849343489/RxOp0eNq_200x200.jpg)
“Branded pharmaceutical corporations completely reoriented their business models to take advantage of the Hatch-Waxman Act’s many concessions and loopholes.” - Tahir Amin
![Madhu Pai, MD, PhD (@paimadhu) 's Twitter Profile Photo Madhu Pai, MD, PhD (@paimadhu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1817368589403328513/9wYMUyMb_200x200.jpg)
![Institute of Tropical Medicine Antwerp (@itmantwerp) 's Twitter Profile Photo Institute of Tropical Medicine Antwerp (@itmantwerp) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1466358779218472965/eNmXEgN6_200x200.png)
🏙🌡 Urbanisation, ageing, climate change... How we can prepare our health systems for the unknown? Listen to our podcast for answers. Listen to our podcast Transmission to find out! Saleh Aljadeeah 🎧open.spotify.com/show/1V1sqmbBr…
![Just Treatment 💊 (@justtreatment) 's Twitter Profile Photo Just Treatment 💊 (@justtreatment) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1521533044632522753/n9lA93fp_200x200.jpg)
🚨BREAKING: #RightToBreathe campaigners & allies protest outside Vertex Pharmaceuticals HQ in Boston! We have delivered a petition signed by over 142,000 people, demanding that Vertex makes its lifesaving #cysticfibrosis medicine accessible to everyone, everywhere. 🫁🌍
![Just Treatment 💊 (@justtreatment) on Twitter photo 🚨BREAKING: #RightToBreathe campaigners & allies protest outside <a href="/VertexPharma/">Vertex Pharmaceuticals</a> HQ in Boston!
We have delivered a petition signed by over 142,000 people, demanding that Vertex makes its lifesaving #cysticfibrosis medicine accessible to everyone, everywhere. 🫁🌍 🚨BREAKING: #RightToBreathe campaigners & allies protest outside <a href="/VertexPharma/">Vertex Pharmaceuticals</a> HQ in Boston!
We have delivered a petition signed by over 142,000 people, demanding that Vertex makes its lifesaving #cysticfibrosis medicine accessible to everyone, everywhere. 🫁🌍](https://pbs.twimg.com/media/GYfoff_XkAEm_t4.jpg)
![Bhekisisa (@bhekisisa_mg) 's Twitter Profile Photo Bhekisisa (@bhekisisa_mg) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1171397514236485632/z2vrTXr7_200x200.jpg)
“Unconscionable, unconstitutional and a clear abuse of intellectual property rights.” Read what Health Justice Initiative - HJI founder Fatima Hassan has to say about South Africa’s insulin pen shortage Christina Pitt. bhekisisa.org/health-news-so…
![Just Treatment 💊 (@justtreatment) 's Twitter Profile Photo Just Treatment 💊 (@justtreatment) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1521533044632522753/n9lA93fp_200x200.jpg)
📢 In Boston yesterday, 80+ clinicians & allies joined us outside Vertex Pharmaceuticals to protest their $326k/year price for lifesaving #cysticfibrosis meds that can be made for under $6k. We delivered a petition signed by 142,000+ demanding global access. Please share!⬇️#NACFC